On the public citation graph

Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study

https://doi.org/10.1371/journal.pmed.1002197
0 signed · 291 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/gcc.10314openalex-snapshot
Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas
inferredcites →https://doi.org/10.1007/s00277-015-2303-5openalex-snapshot
Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis
inferredcites →https://doi.org/10.1016/j.cell.2013.01.019openalex-snapshot
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
inferredcites →https://doi.org/10.1016/j.celrep.2013.12.027openalex-snapshot
Genetics of Follicular Lymphoma Transformation
inferredcites →https://doi.org/10.1016/s1470-2045(15)00169-2openalex-snapshot
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
inferredcites →https://doi.org/10.1023/a:1008265532487openalex-snapshot
Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locations
inferredcites →https://doi.org/10.1038/leu.2014.251openalex-snapshot
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
inferredcites →https://doi.org/10.1038/nature10738openalex-snapshot
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
inferredcites →https://doi.org/10.1038/nature10983openalex-snapshot
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
inferredcites →https://doi.org/10.1038/nature13765openalex-snapshot
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma
inferredcites →https://doi.org/10.1038/nature15395openalex-snapshot
Mutations driving CLL and their evolution in progression and relapse
inferredcites →https://doi.org/10.1038/nature16478openalex-snapshot
Divergent clonal selection dominates medulloblastoma at recurrence
inferredcites →https://doi.org/10.1038/ng.2856openalex-snapshot
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma
inferredcites →https://doi.org/10.1038/nmeth.2883openalex-snapshot
PyClone: statistical inference of clonal population structure in cancer
inferredcites →https://doi.org/10.1038/sj.leu.2404696openalex-snapshot
Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma
inferredcites →https://doi.org/10.1056/nejm198701083160204openalex-snapshot
Multiple Recurrent Genomic Defects in Follicular Lymphoma
inferredcites →https://doi.org/10.1056/nejmoa1106968openalex-snapshot
Clonal Architecture of Secondary Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1073/pnas.132253599openalex-snapshot
Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c - myc and its regulated genes
inferredcites →https://doi.org/10.1084/jem.20131448openalex-snapshot
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
inferredcites →https://doi.org/10.1093/bioinformatics/btv003openalex-snapshot
Clonality inference in multiple tumor samples using phylogeny
inferredcites →https://doi.org/10.1111/j.1365-2141.2006.06439.xopenalex-snapshot
Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-0752openalex-snapshot
Clonal Evolution in t(14;18)-Positive Follicular Lymphoma, Evidence for Multiple Common Pathways, and Frequent Parallel Clonal Evolution
inferredcites →https://doi.org/10.1158/1078-0432.ccr-13-2175openalex-snapshot
Inactivation of the CDKN2A Tumor-Suppressor Gene by Deletion or Methylation Is Common at Diagnosis in Follicular Lymphoma and Associated with Poor Clinical Outcome
inferredcites →https://doi.org/10.1182/blood-2008-02-140616openalex-snapshot
Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances
inferredcites →https://doi.org/10.1182/blood-2008-05-154013openalex-snapshot
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
inferredcites →https://doi.org/10.1182/blood-2008-08-174839openalex-snapshot
Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone
inferredcites →https://doi.org/10.1182/blood-2008-08-174953openalex-snapshot
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation
inferredcites →https://doi.org/10.1182/blood-2010-05-282780openalex-snapshot
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
inferredcites →https://doi.org/10.1182/blood-2013-03-491514openalex-snapshot
Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
inferredcites →https://doi.org/10.1182/blood-2015-01-621375openalex-snapshot
Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)
inferredcites →https://doi.org/10.1182/blood-2016-05-717355openalex-snapshot
Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy
inferredcites →https://doi.org/10.1182/blood.v80.3.758.758openalex-snapshot
MYC rearrangements in histologically progressed follicular lymphomas
inferredcites →https://doi.org/10.1182/blood.v82.7.1994.1994openalex-snapshot
p53 mutation is associated with progression in follicular lymphomas
inferredcites →https://doi.org/10.1182/blood.v82.8.2289.2289openalex-snapshot
p53 mutations are associated with histologic transformation of follicular lymphoma
inferredcites →https://doi.org/10.1182/blood.v84.4.1043.1043openalex-snapshot
Prognostic value of chromosomal abnormalities in follicular lymphoma
inferredcites →https://doi.org/10.1182/blood.v89.11.3909openalex-snapshot
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1200/jco.2006.09.3260openalex-snapshot
Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
inferredcites →https://doi.org/10.1200/jco.2008.16.0283openalex-snapshot
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1200/jco.2012.48.3990openalex-snapshot
Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource
inferredcites →https://doi.org/10.1200/jco.2014.59.7534openalex-snapshot
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
inferredcites →https://doi.org/10.1534/genetics.111.132027openalex-snapshot
Emergent Neutrality in Adaptive Asexual Evolution
inferredcites →https://doi.org/10.3109/10428194.2014.885513openalex-snapshot
Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis
inferredcites →https://doi.org/10.3324/haematol.2012.082412openalex-snapshot
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4180807openalex-extracted
A Multi-Scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes
inferred← citeshttps://doi.org/10.1002/9781119819950.ch14openalex-snapshot
The Role of Epigenetic Dysregulation in Lymphoma Biology
inferred← citeshttps://doi.org/10.1002/eji.202149235openalex-snapshot
Heterogeneity of germinal center B cells: New insights from single‐cell studies
inferred← citeshttps://doi.org/10.1002/hem3.50openalex-snapshot
Analysis of immunoglobulin/T‐cell receptor repertoires by high‐throughput RNA sequencing reveals a continuous dynamic of positive clonal selection in follicular lymphoma
inferred← citeshttps://doi.org/10.1002/hem3.70382openalex-snapshot
Genomic heterogeneity in primary cutaneous follicular center lymphomas reveals different clinicopathological subgroups
inferred← citeshttps://doi.org/10.1002/hon.2508openalex-snapshot
Novel acquisitions on biology and management of transformed follicular lymphoma
inferred← citeshttps://doi.org/10.1002/hon.2674openalex-snapshot
m7FLIPI and targeted sequencing in high‐risk follicular lymphoma
inferred← citeshttps://doi.org/10.1002/hon.3132openalex-snapshot
Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors
inferred← citeshttps://doi.org/10.1002/hon.3138openalex-snapshot
Update on follicular lymphoma
inferred← citeshttps://doi.org/10.1002/hon.3205openalex-snapshot
Personalised therapy in follicular lymphoma – is the dial turning?
inferred← citeshttps://doi.org/10.1002/hon.3272openalex-snapshot
Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first‐line treatment: A 15‐year follow‐up of patients with advanced follicular lymphoma in JCOG0203
inferred← citeshttps://doi.org/10.1002/hon.3282openalex-snapshot
Clonal dynamics of Richter transformation in chronic lymphocytic leukemia
inferred← citeshttps://doi.org/10.1002/hon.70140openalex-snapshot
Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective
inferred← citeshttps://doi.org/10.1002/jcp.27407openalex-snapshot
Tumor suppressors BTG1 and BTG2: Beyond growth control
inferred← citeshttps://doi.org/10.1002/jha2.116openalex-snapshot
Genetic aberrations ofNLRC5are associated with downregulated MHC‐I antigen presentation and impaired T‐cell immunity in follicular lymphoma
inferred← citeshttps://doi.org/10.1002/jha2.212openalex-snapshot
Liquid biopsy in lymphoma: Is it primed for clinical translation?
inferred← citeshttps://doi.org/10.1002/path.5043openalex-snapshot
Novel insights into the disease dynamics of B‐cell lymphomas in the Genomics Era
inferred← citeshttps://doi.org/10.1002/path.6246openalex-snapshot
The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research
inferred← citeshttps://doi.org/10.1002/path.6476openalex-snapshot
Mutation profiling in differential diagnosis between TdT ‐positive high‐grade/large B‐cell lymphoma and B‐lymphoblastic leukaemia/lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-030-00362-3_2openalex-snapshot
Pathology and Molecular Pathogenesis of DLBCL and Related Entities
inferred← citeshttps://doi.org/10.1007/978-3-030-26211-2_8openalex-snapshot
Transformed Follicular Lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-030-55989-2_2openalex-snapshot
Molecular Genetics in Indolent Lymphomas
inferred← citeshttps://doi.org/10.1007/978-3-031-22881-0_2openalex-snapshot
Molekulargenetik bei indolenten Lymphomen
inferred← citeshttps://doi.org/10.1007/978-3-319-28845-1_3891-1openalex-snapshot
Follicular Lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-319-95309-0_3891openalex-snapshot
Follicular Lymphoma
inferred← citeshttps://doi.org/10.1007/s00277-017-3154-zopenalex-snapshot
Current prognostic and predictive factors in follicular lymphoma
inferred← citeshttps://doi.org/10.1007/s00277-022-04947-zopenalex-snapshot
Clinical usefulness of a novel classification of T cell distribution patterns in the tumor microenvironment of follicular lymphoma to detect transformation
inferred← citeshttps://doi.org/10.1007/s00277-024-05618-xopenalex-snapshot
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience
inferred← citeshttps://doi.org/10.1007/s00292-021-01011-xopenalex-snapshot
Die genetische Evolution der in situ follikulären Neoplasie zum t(14;18)-positiven aggressiven B‑Zell-Lymphom
inferred← citeshttps://doi.org/10.1007/s00428-024-03774-zopenalex-snapshot
Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
inferred← citeshttps://doi.org/10.1007/s11864-025-01297-6openalex-snapshot
Advances in Personalized Treatment and Prognostic Factors of Follicular Lymphoma
inferred← citeshttps://doi.org/10.1007/s12094-023-03307-1openalex-snapshot
A genetic profiling guideline to support diagnosis and clinical management of lymphomas
inferred← citeshttps://doi.org/10.1007/s12185-019-02656-4openalex-snapshot
Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma
inferred← citeshttps://doi.org/10.1007/s12185-022-03461-2openalex-snapshot
Biological and clinical significance of epigenetic alterations in B-cell lymphomas
inferred← citeshttps://doi.org/10.1007/s12185-025-03939-9openalex-snapshot
Recent advances in understanding of pathogenesis and treatment development for diffuse large B-cell lymphoma and follicular lymphoma
inferred← citeshttps://doi.org/10.1007/s12253-020-00843-xopenalex-snapshot
Grade I, II and III Follicular Lymphomas Express Ig VH Genes with Different Patterns of Somatic Mutation
inferred← citeshttps://doi.org/10.1007/s12288-025-02227-0openalex-snapshot
Transformed Follicular Lymphoma: Case Series and Narrative review
inferred← citeshttps://doi.org/10.1016/b978-0-12-816228-6.00016-7openalex-snapshot
Tackling the complexities of orphan GPCR ligand discovery with rationally assisted approaches
inferred← citeshttps://doi.org/10.1016/bs.ai.2021.05.002openalex-snapshot
Follicular lymphoma dynamics
inferred← citeshttps://doi.org/10.1016/j.bbmt.2018.03.022openalex-snapshot
Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group
inferred← citeshttps://doi.org/10.1016/j.beha.2017.10.005openalex-snapshot
Transformation of follicular lymphoma – Why does it happen and can it be prevented?
inferred← citeshttps://doi.org/10.1016/j.beha.2017.10.006openalex-snapshot
Pathogenesis of follicular lymphoma
inferred← citeshttps://doi.org/10.1016/j.beha.2017.11.002openalex-snapshot
Risk stratification in follicular lymphoma
inferred← citeshttps://doi.org/10.1016/j.beha.2018.07.008openalex-snapshot
An update in treating transformed lymphoma
inferred← citeshttps://doi.org/10.1016/j.biopha.2020.110069openalex-snapshot
The emerging role of XBP1 in cancer
inferred← citeshttps://doi.org/10.1016/j.blre.2019.03.006openalex-snapshot
Recent landmark studies in follicular lymphoma
inferred← citeshttps://doi.org/10.1016/j.blre.2022.100969openalex-snapshot
Neoantigens – the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders
inferred← citeshttps://doi.org/10.1016/j.blre.2023.101099openalex-snapshot
Thinking “outside the germinal center”: Re-educating T cells to combat follicular lymphoma
inferred← citeshttps://doi.org/10.1016/j.bneo.2024.100044openalex-snapshot
Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapy
inferred← citeshttps://doi.org/10.1016/j.cancergen.2026.02.007openalex-snapshot
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors
inferred← citeshttps://doi.org/10.1016/j.ccell.2020.03.016openalex-snapshot
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.ccell.2020.04.004openalex-snapshot
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response
inferred← citeshttps://doi.org/10.1016/j.ccell.2024.02.001openalex-snapshot
Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
inferred← citeshttps://doi.org/10.1016/j.ccell.2024.05.011openalex-snapshot
Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma
inferred← citeshttps://doi.org/10.1016/j.cellsig.2017.08.002openalex-snapshot
The role of G protein-coupled receptors in lymphoid malignancies
inferred← citeshttps://doi.org/10.1016/j.celrep.2021.109372openalex-snapshot
Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs
inferred← citeshttps://doi.org/10.1016/j.esmorc.2025.100040openalex-snapshot
A multi-omics analysis of transformed nodal marginal zone lymphoma
inferred← citeshttps://doi.org/10.1016/j.hoc.2020.02.002openalex-snapshot
Clinical and Biological Prognostic Factors in Follicular Lymphoma
inferred← citeshttps://doi.org/10.1016/j.hoc.2020.02.006openalex-snapshot
Cellular Therapy in Follicular Lymphoma
inferred← citeshttps://doi.org/10.1016/j.hoc.2020.02.009openalex-snapshot
Early Progression of Follicular Lymphoma
inferred← citeshttps://doi.org/10.1016/j.hoc.2020.02.010openalex-snapshot
The Biological Basis of Histologic Transformation
inferred← citeshttps://doi.org/10.1016/j.hoc.2020.03.001openalex-snapshot
Treatment of Histologic Transformation
inferred← citeshttps://doi.org/10.1016/j.humpath.2021.04.014openalex-snapshot
Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma
inferred← citeshttps://doi.org/10.1016/j.humpath.2024.105679openalex-snapshot
Clinical use of circulating tumor DNA analysis in patients with lymphoma
inferred← citeshttps://doi.org/10.1016/j.intimp.2022.109235openalex-snapshot
Tumor-associated macrophages in lymphoma: From mechanisms to therapy
inferred← citeshttps://doi.org/10.1016/j.jmoldx.2017.11.010openalex-snapshot
Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management
inferred← citeshttps://doi.org/10.1016/j.leukres.2026.108317openalex-snapshot
Prognostic impact of high-grade transformation in low-grade B-cell lymphomas: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.lpm.2019.07.024openalex-snapshot
Actualités dans le lymphome folliculaire
inferred← citeshttps://doi.org/10.1016/j.modpat.2024.100516openalex-snapshot
Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma
inferred← citeshttps://doi.org/10.1016/j.modpat.2026.101055openalex-snapshot
Oncogenic Role of BCL6 Rearrangement: A Focus on Follicular and Marginal Zone Lymphomas
inferred← citeshttps://doi.org/10.1016/j.path.2023.02.001openalex-snapshot
Navigating the Heterogeneity of Follicular Lymphoma and its Many Variants
inferred← citeshttps://doi.org/10.1016/j.pathol.2019.09.010openalex-snapshot
Pathology and diagnosis of follicular lymphoma and related entities
inferred← citeshttps://doi.org/10.1016/j.yamp.2024.07.002openalex-snapshot
Molecular Profiling of Small Mature B Cell Lymphomas; New Insights on Diagnosis and Treatment
inferred← citeshttps://doi.org/10.1016/j.yexmp.2021.104606openalex-snapshot
Application of high-throughput gene sequencing in lymphoma
inferred← citeshttps://doi.org/10.1016/s1470-2045(18)30114-1openalex-snapshot
Predicting early relapse in follicular lymphoma: have we turned a corner?
inferred← citeshttps://doi.org/10.1016/s2152-2650(21)01256-8openalex-snapshot
Molecular Pathogenesis of Follicular Lymphoma and Its Relevance to Clinical Practice
inferred← citeshttps://doi.org/10.1016/s2152-2650(26)00339-3openalex-snapshot
EXABS-221-IBCL: Can We Personalize Care in FL?
inferred← citeshttps://doi.org/10.1016/s2352-3026(18)30093-0openalex-snapshot
Rituximab as a first step in tackling transformation
inferred← citeshttps://doi.org/10.1038/modpathol.2017.58openalex-snapshot
Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms
inferred← citeshttps://doi.org/10.1038/nmeth.4303openalex-snapshot
E-scape: interactive visualization of single-cell phylogenetics and cancer evolution
inferred← citeshttps://doi.org/10.1038/nrc.2017.127openalex-snapshot
From genetics to the clinic: a translational perspective on follicular lymphoma
inferred← citeshttps://doi.org/10.1038/s41375-018-0043-yopenalex-snapshot
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
inferred← citeshttps://doi.org/10.1038/s41375-019-0691-6openalex-snapshot
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit
inferred← citeshttps://doi.org/10.1038/s41375-022-01618-wopenalex-snapshot
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
inferred← citeshttps://doi.org/10.1038/s41375-026-02868-8openalex-snapshot
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma
inferred← citeshttps://doi.org/10.1038/s41408-023-00847-1openalex-snapshot
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era
inferred← citeshttps://doi.org/10.1038/s41408-024-01111-wopenalex-snapshot
Identification of genetic subtypes in follicular lymphoma
inferred← citeshttps://doi.org/10.1038/s41408-024-01124-5openalex-snapshot
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma
inferred← citeshttps://doi.org/10.1038/s41467-018-06354-3openalex-snapshot
Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1038/s41467-019-12494-xopenalex-snapshot
Genetic modification of primary human B cells to model high-grade lymphoma
inferred← citeshttps://doi.org/10.1038/s41467-022-34408-0openalex-snapshot
Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk
inferred← citeshttps://doi.org/10.1038/s41467-024-47012-1openalex-snapshot
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
inferred← citeshttps://doi.org/10.1038/s41467-024-47701-xopenalex-snapshot
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
inferred← citeshttps://doi.org/10.1038/s41572-019-0132-xopenalex-snapshot
Follicular lymphoma
inferred← citeshttps://doi.org/10.1038/s41586-019-1003-zopenalex-snapshot
S-Geranylgeranyl-l-glutathione is a ligand for human B cell-confinement receptor P2RY8
inferred← citeshttps://doi.org/10.1038/s41588-023-01561-1openalex-snapshot
Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression
inferred← citeshttps://doi.org/10.1038/s41590-018-0181-4openalex-snapshot
Human germinal center transcriptional programs are de-synchronized in B cell lymphoma
inferred← citeshttps://doi.org/10.1038/s41591-020-0757-zopenalex-snapshot
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
inferred← citeshttps://doi.org/10.1038/s41596-021-00506-4openalex-snapshot
Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cells
inferred← citeshttps://doi.org/10.1038/s41598-017-13338-8openalex-snapshot
Engineered in-vitro cell line mixtures and robust evaluation of computational methods for clonal decomposition and longitudinal dynamics in cancer
inferred← citeshttps://doi.org/10.1038/s41598-017-14150-0openalex-snapshot
High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif
inferred← citeshttps://doi.org/10.1038/s41598-018-37389-7openalex-snapshot
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
inferred← citeshttps://doi.org/10.1038/s41598-024-81693-4openalex-snapshot
Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformation
inferred← citeshttps://doi.org/10.1038/s41598-026-43710-6openalex-snapshot
Splice-site mutations in POU2AF1 are associated with B-cell lymphomagenesis and therapeutic response
inferred← citeshttps://doi.org/10.1038/s42003-019-0291-zopenalex-snapshot
Somatic mutation detection and classification through probabilistic integration of clonal population information
inferred← citeshttps://doi.org/10.1038/s42255-019-0098-8openalex-snapshot
Oncogenic Rag GTPase signalling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR
inferred← citeshttps://doi.org/10.1053/j.seminhematol.2023.06.003openalex-snapshot
Clinical applications of circulating tumor DNA in indolent B-cell lymphomas
inferred← citeshttps://doi.org/10.1053/j.seminhematol.2023.08.001openalex-snapshot
Special issue on circulating tumor DNA: Introductory editorial
inferred← citeshttps://doi.org/10.1053/j.seminhematol.2023.11.002openalex-snapshot
DLBCL arising from indolent lymphomas: How are they different?
inferred← citeshttps://doi.org/10.1053/j.seminhematol.2023.11.006openalex-snapshot
Biological heterogeneity in diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2018.07.005openalex-snapshot
New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs
inferred← citeshttps://doi.org/10.1080/10428194.2019.1594212openalex-snapshot
Refractoriness to rituximab-based therapy and elevated serum B2-microglobulin predict for inferior survival in marginal zone lymphoma
inferred← citeshttps://doi.org/10.1080/10428194.2020.1762883openalex-snapshot
Follicular lymphoma genomics
inferred← citeshttps://doi.org/10.1080/10428194.2020.1791857openalex-snapshot
Follicular lymphoma – a better understanding to transform outcomes?
inferred← citeshttps://doi.org/10.1080/10428194.2025.2556961openalex-snapshot
Genetic analysis of cell-free DNA in follicular lymphoma in comparison with tissue-derived DNA
inferred← citeshttps://doi.org/10.1080/17474086.2017.1326812openalex-snapshot
Follicular lymphomas and their transformation: Past and current research
inferred← citeshttps://doi.org/10.1080/17474086.2020.1690987openalex-snapshot
Histological transformation in malignant lymphoma: a possible role of PET/CT and circulating tumor DNA as noninvasive diagnostic tools
inferred← citeshttps://doi.org/10.1080/17474086.2020.1850252openalex-snapshot
An analysis of genetic targets for guiding clinical management of follicular lymphoma
inferred← citeshttps://doi.org/10.1080/23723556.2017.1365107openalex-snapshot
Sestrin1, a tumor suppressor that can be rescued
inferred← citeshttps://doi.org/10.1097/coc.0000000000001282openalex-snapshot
Surveillance Strategies in Follicular Non-Hodgkin’s Lymphoma’s Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging Studies
inferred← citeshttps://doi.org/10.1097/hs9.0000000000000213openalex-snapshot
Follicular lymphoma genomics
inferred← citeshttps://doi.org/10.1097/hs9.0000000000000579openalex-snapshot
The Premalignant Ancestor Cell of t(14;18)+ Lymphoma
inferred← citeshttps://doi.org/10.1097/moh.0000000000000437openalex-snapshot
Precision medicine and lymphoma
inferred← citeshttps://doi.org/10.1097/pap.0000000000000481openalex-snapshot
Diagnosis and Classification of Follicular Lymphoma and Related Entities
inferred← citeshttps://doi.org/10.1097/pas.0000000000001726openalex-snapshot
High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B
inferred← citeshttps://doi.org/10.1097/pcr.0000000000000330openalex-snapshot
Lymphoblastic Transformation of Follicular Lymphoma: A Case Report and Review of the Literature
inferred← citeshttps://doi.org/10.1101/191759openalex-snapshot
MuClone: Somatic mutation detection and classification through probabilistic integration of clonal population structure
inferred← citeshttps://doi.org/10.1101/2021.05.22.445261openalex-snapshot
Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1101/2022.04.06.487285openalex-snapshot
Functional plasticity and recurrent cell states of malignant B cells in follicular lymphoma
inferred← citeshttps://doi.org/10.1101/2022.11.17.516951openalex-snapshot
Integrated single cell analysis reveals co-evolution of malignant B cells and the tumor microenvironment in transformed follicular lymphoma
inferred← citeshttps://doi.org/10.1101/2023.09.05.556242openalex-snapshot
CREBBP lysine acetyltransferase domain mutations create zombie enzymes that alter chromatin loading dynamics and prevent EP300 redundancy
inferred← citeshttps://doi.org/10.1101/2025.09.18.25335809openalex-snapshot
DLBCLone: A unified framework for neighbourhood-based genetic subtyping of lymphomas
inferred← citeshttps://doi.org/10.1101/cshperspect.a029603openalex-snapshot
Observing Clonal Dynamics across Spatiotemporal Axes: A Prelude to Quantitative Fitness Models for Cancer
inferred← citeshttps://doi.org/10.1111/bjh.17251openalex-snapshot
Circulating tumour DNA in B‐cell lymphomas: current state and future prospects
inferred← citeshttps://doi.org/10.1111/bjh.17383openalex-snapshot
Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation
inferred← citeshttps://doi.org/10.1111/bjh.17990openalex-snapshot
The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells
inferred← citeshttps://doi.org/10.1111/bjh.19770openalex-snapshot
Time to lymphoma treatment within 24 months in ‘watch and wait’ follicular lymphoma is associated with inferior outcomes: A multicentre analysis
inferred← citeshttps://doi.org/10.1111/cas.14176openalex-snapshot
Mutations found in cell‐free DNA s of patients with malignant lymphoma at remission can derive from clonal hematopoiesis
inferred← citeshttps://doi.org/10.1111/his.15344openalex-snapshot
Follicular lymphoma research: an open dialogue for a collaborative roadmap
inferred← citeshttps://doi.org/10.1111/imr.12745openalex-snapshot
Molecular pathogenesis of germinal center‐derived B cell lymphomas
inferred← citeshttps://doi.org/10.1111/imr.12860openalex-snapshot
T follicular helper cells in germinal center B cell selection and lymphomagenesis
inferred← citeshttps://doi.org/10.1111/joim.13674openalex-snapshot
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma
inferred← citeshttps://doi.org/10.1111/pin.70167openalex-snapshot
Comparative Analysis of the Clinicopathological Features of Follicular Lymphoma With and Without EZH2 Y646 Mutation
inferred← citeshttps://doi.org/10.1126/sciimmunol.abg1101openalex-snapshot
Abcc1 and Ggt5 support lymphocyte guidance through export and catabolism of S -geranylgeranyl- l -glutathione
inferred← citeshttps://doi.org/10.1126/scitranslmed.aak9969openalex-snapshot
Genetic and epigenetic inactivation of SESTRIN1 controls mTORC1 and response to EZH2 inhibition in follicular lymphoma
inferred← citeshttps://doi.org/10.1134/s1022795424701278openalex-snapshot
Integrative RNA-Sequencing Analysis Reveals T-Cell Exhaustion Signatures and Immune Cell Infiltration in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1136/jcp-2023-209262openalex-snapshot
Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication
inferred← citeshttps://doi.org/10.1136/jcp-2024-209880openalex-snapshot
Mutational profile dynamics in follicular lymphoma and large cell transformation
inferred← citeshttps://doi.org/10.1146/annurev-pathmechdis-111523-023413openalex-snapshot
Genomic Taxonomy of Aggressive B-Cell Lymphoid Neoplasms
inferred← citeshttps://doi.org/10.1158/1078-0432.c.6532949.v1openalex-snapshot
Data from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-22-1654openalex-snapshot
Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
inferred← citeshttps://doi.org/10.1158/2643-3230.bcd-21-0075openalex-snapshot
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
inferred← citeshttps://doi.org/10.1158/2643-3230.c.6550995openalex-snapshot
Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
inferred← citeshttps://doi.org/10.1182/blood-2016-08-733469openalex-snapshot
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
inferred← citeshttps://doi.org/10.1182/blood-2017-03-691345openalex-snapshot
Can histologic transformation of follicular lymphoma be predicted and prevented?
inferred← citeshttps://doi.org/10.1182/blood-2017-07-737353openalex-snapshot
The promises and challenges of using gene mutations for patient stratification in follicular lymphoma
inferred← citeshttps://doi.org/10.1182/blood-2017-08-737361openalex-snapshot
Chromatin modifying gene mutations in follicular lymphoma
inferred← citeshttps://doi.org/10.1182/blood-2017-08-799080openalex-snapshot
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy
inferred← citeshttps://doi.org/10.1182/blood-2017-11-764332openalex-snapshot
Genetics of diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1182/blood-2018-08-822148openalex-snapshot
How I treat early-relapsing follicular lymphoma
inferred← citeshttps://doi.org/10.1182/blood.2019000258openalex-snapshot
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
inferred← citeshttps://doi.org/10.1182/blood.2021011362openalex-snapshot
Discordant solutions to discordant problems
inferred← citeshttps://doi.org/10.1182/blood.2022016095openalex-snapshot
Minimal information for reporting a genomics experiment
inferred← citeshttps://doi.org/10.1182/blood.2022018719openalex-snapshot
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns
inferred← citeshttps://doi.org/10.1182/blood.2023020999openalex-snapshot
The follicular lymphoma tumor microenvironment at single-cell and spatial resolution
inferred← citeshttps://doi.org/10.1182/blood.2024024251openalex-snapshot
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
inferred← citeshttps://doi.org/10.1182/blood.2024025603openalex-snapshot
Unbalanced MYC break-apart FISH patterns indicate the presence of a MYC rearrangement in HGBCL-DH-BCL2
inferred← citeshttps://doi.org/10.1182/blood.2024026016openalex-snapshot
An updated understanding of follicular lymphoma transformation
inferred← citeshttps://doi.org/10.1182/blood.2024026020openalex-snapshot
Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics
inferred← citeshttps://doi.org/10.1182/blood.2024026664openalex-snapshot
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement
inferred← citeshttps://doi.org/10.1182/blood.2025031181openalex-snapshot
Differential role of CREBBP missense and truncating mutations in germinal center development and lymphomagenesis
inferred← citeshttps://doi.org/10.1182/bloodadvances.2017008854openalex-snapshot
Mature lymphoid malignancies: origin, stem cells, and chronicity
inferred← citeshttps://doi.org/10.1182/bloodadvances.2020002546openalex-snapshot
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models
inferred← citeshttps://doi.org/10.1182/bloodadvances.2021004528openalex-snapshot
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab
inferred← citeshttps://doi.org/10.1182/bloodadvances.2021005284openalex-snapshot
Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
inferred← citeshttps://doi.org/10.1182/bloodadvances.2022009461openalex-snapshot
Audit of B-cell cancer genes
inferred← citeshttps://doi.org/10.1182/bloodadvances.2022009467openalex-snapshot
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma
inferred← citeshttps://doi.org/10.1182/bloodadvances.2023010779openalex-snapshot
Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303
inferred← citeshttps://doi.org/10.1182/bloodadvances.2023011299openalex-snapshot
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma
inferred← citeshttps://doi.org/10.1182/hematology.2021000264openalex-snapshot
Follicular lymphoma: is there an optimal way to define risk?
inferred← citeshttps://doi.org/10.1182/hematology.2022000361openalex-snapshot
Biology of follicular lymphoma: insights and windows of clinical opportunity
inferred← citeshttps://doi.org/10.1182/hematology.2024000662openalex-snapshot
The POD24 challenge: where do we go from here for early progressors?
inferred← citeshttps://doi.org/10.1186/s12885-022-10070-zopenalex-snapshot
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
inferred← citeshttps://doi.org/10.1186/s13000-018-0758-0openalex-snapshot
KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma
inferred← citeshttps://doi.org/10.1186/s40364-024-00711-9openalex-snapshot
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases
inferred← citeshttps://doi.org/10.1200/edbk_239065openalex-snapshot
One Size Does Not Fit All: Who Benefits From Maintenance After Frontline Therapy for Follicular Lymphoma?
inferred← citeshttps://doi.org/10.1200/edbk_349307openalex-snapshot
Revising the Treatment Pathways in Lymphoma: New Standards of Care—How Do We Choose?
inferred← citeshttps://doi.org/10.1200/jco.18.00400openalex-snapshot
Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts
inferred← citeshttps://doi.org/10.1200/jco.2018.79.3083openalex-snapshot
Progress in Advanced-Stage Follicular Lymphoma
inferred← citeshttps://doi.org/10.1200/jco.23.00570openalex-snapshot
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma
inferred← citeshttps://doi.org/10.1200/jop.19.00691openalex-snapshot
Potential of Circulating Tumor DNA for the Management of Patients With Lymphoma
inferred← citeshttps://doi.org/10.1200/po.23.00177openalex-snapshot
Donor-Derived Follicular Lymphoma After Kidney Transplantation: A Case Report
inferred← citeshttps://doi.org/10.1371/journal.pone.0212813openalex-snapshot
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
inferred← citeshttps://doi.org/10.1371/journal.pone.0233449openalex-snapshot
Glycolytic biomarkers predict transformation in patients with follicular lymphoma
inferred← citeshttps://doi.org/10.14288/1.0313405openalex-snapshot
E-scape : interactive visualization of single cell phylogenetics and spatio-temporal evolution in cancer
inferred← citeshttps://doi.org/10.15586/jkcvhl.2017.70openalex-snapshot
The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review
inferred← citeshttps://doi.org/10.1634/theoncologist.2019-0138openalex-snapshot
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs
inferred← citeshttps://doi.org/10.1684/hma.2019.1479openalex-snapshot
Predict the prognosis of follicular lymphoma
inferred← citeshttps://doi.org/10.21037/aol-20-46openalex-snapshot
Predicting early progression in follicular lymphoma
inferred← citeshttps://doi.org/10.21037/aol-21-1openalex-snapshot
Management of relapsed follicular lymphoma
showing the first 200 of 248
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.